Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Edith Zemanick

Concepts (234)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Cystic Fibrosis
81
2026
1158
14.780
Why?
Cystic Fibrosis Transmembrane Conductance Regulator
24
2026
370
6.420
Why?
Sweat
8
2026
51
3.450
Why?
Chlorides
6
2026
142
3.220
Why?
Microbiota
13
2024
781
2.890
Why?
Quinolones
17
2026
201
2.820
Why?
Chloride Channel Agonists
11
2026
109
2.790
Why?
Pseudomonas Infections
12
2023
221
2.730
Why?
Aminophenols
17
2026
201
2.550
Why?
Anti-Bacterial Agents
24
2025
1907
2.490
Why?
Pseudomonas aeruginosa
13
2023
356
2.480
Why?
Respiratory Tract Infections
7
2026
397
2.350
Why?
Sputum
10
2025
308
2.120
Why?
Benzodioxoles
13
2026
158
2.050
Why?
Indoles
10
2026
501
2.040
Why?
Specimen Handling
4
2025
186
1.890
Why?
Respiratory System
6
2021
149
1.360
Why?
Drug Combinations
9
2026
390
1.310
Why?
Oropharynx
3
2021
46
1.200
Why?
Pyrazoles
8
2026
509
1.150
Why?
Metagenome
4
2013
149
1.110
Why?
DNA, Bacterial
6
2019
342
1.100
Why?
Lung
9
2023
4109
0.970
Why?
Aminopyridines
6
2026
127
0.890
Why?
Cough
1
2025
124
0.860
Why?
Child
41
2026
22633
0.860
Why?
Inflammation
6
2017
2878
0.850
Why?
Bronchoalveolar Lavage Fluid
7
2019
636
0.850
Why?
Anti-Infective Agents
2
2023
242
0.790
Why?
Humans
82
2026
144759
0.770
Why?
Aspergillosis, Allergic Bronchopulmonary
1
2021
11
0.710
Why?
RNA, Ribosomal, 16S
5
2023
558
0.650
Why?
Adolescent
29
2026
22428
0.630
Why?
Microbial Sensitivity Tests
3
2021
370
0.620
Why?
Pyridines
7
2026
605
0.620
Why?
Drug Resistance, Bacterial
2
2021
196
0.590
Why?
Male
43
2026
72315
0.540
Why?
Female
45
2026
78271
0.530
Why?
Genetic Therapy
4
2023
313
0.510
Why?
Bacteria
8
2023
889
0.500
Why?
beta-Lactams
3
2023
32
0.500
Why?
Nasopharynx
1
2016
73
0.460
Why?
Respiratory Function Tests
5
2025
547
0.460
Why?
Meconium Ileus
2
2026
12
0.450
Why?
Carrier State
1
2016
79
0.450
Why?
Pyrrolidines
6
2026
125
0.450
Why?
Lung Diseases
3
2018
787
0.430
Why?
Child, Preschool
14
2025
11787
0.420
Why?
Bacteria, Anaerobic
2
2011
25
0.420
Why?
Vital Capacity
1
2014
290
0.400
Why?
Respiratory Sounds
1
2014
105
0.400
Why?
Mutation
12
2023
4089
0.390
Why?
Genotype
4
2026
1833
0.390
Why?
Saliva
1
2015
249
0.380
Why?
Bronchiectasis
1
2013
112
0.350
Why?
Precision Medicine
1
2016
457
0.350
Why?
Age Factors
2
2025
3333
0.340
Why?
Quinolines
4
2026
193
0.340
Why?
Feasibility Studies
2
2025
1095
0.330
Why?
Polymerase Chain Reaction
2
2011
1054
0.330
Why?
Disease Progression
6
2025
2847
0.310
Why?
Disease Management
1
2014
645
0.310
Why?
Cytokines
2
2015
2061
0.300
Why?
Young Adult
14
2026
14105
0.300
Why?
Adult
18
2026
40449
0.290
Why?
Cardiovascular Diseases
1
2021
2168
0.290
Why?
Pneumonia, Bacterial
1
2009
113
0.280
Why?
Case-Control Studies
5
2025
3604
0.260
Why?
Infant
7
2023
10034
0.260
Why?
Biofilms
2
2020
278
0.260
Why?
Clinical Trials as Topic
3
2024
1053
0.250
Why?
Thiazolidines
1
2026
13
0.250
Why?
Quinuclidines
1
2026
11
0.240
Why?
Treatment Outcome
10
2026
11679
0.240
Why?
Diabetes Mellitus
2
2025
1098
0.240
Why?
Oxygen
2
2020
995
0.210
Why?
Prospective Studies
7
2023
7990
0.210
Why?
Endpoint Determination
1
2024
83
0.200
Why?
Monitoring, Physiologic
1
2025
289
0.200
Why?
Olfaction Disorders
1
2023
70
0.190
Why?
Fetal Diseases
1
2024
191
0.190
Why?
Central Venous Catheters
1
2023
52
0.180
Why?
C-Reactive Protein
1
2025
416
0.180
Why?
Respiratory Syncytial Virus Infections
1
2024
136
0.180
Why?
Advisory Committees
1
2024
228
0.180
Why?
Methicillin-Resistant Staphylococcus aureus
2
2016
248
0.180
Why?
Catheter-Related Infections
1
2023
94
0.180
Why?
Aspergillus fumigatus
1
2021
25
0.180
Why?
Catheterization, Peripheral
1
2023
118
0.170
Why?
Antimicrobial Cationic Peptides
2
2019
86
0.170
Why?
Staphylococcal Infections
2
2016
388
0.170
Why?
Catheterization, Central Venous
1
2023
122
0.170
Why?
Tobramycin
3
2023
54
0.170
Why?
Trachea
1
2023
261
0.170
Why?
Quality Improvement
3
2019
1289
0.170
Why?
Venous Thrombosis
1
2023
194
0.160
Why?
Quality of Life
3
2023
3185
0.160
Why?
Pseudomonas
2
2022
33
0.160
Why?
Respiratory System Agents
1
2020
23
0.150
Why?
Luminescent Measurements
1
2019
76
0.150
Why?
Bacteriological Techniques
1
2019
68
0.150
Why?
International Cooperation
1
2019
198
0.140
Why?
Genetic Variation
2
2021
983
0.140
Why?
United States
6
2025
15966
0.140
Why?
Bronchopulmonary Dysplasia
1
2024
410
0.140
Why?
Bacterial Infections
1
2020
246
0.140
Why?
Critical Pathways
1
2019
108
0.140
Why?
Drug Prescriptions
1
2020
284
0.140
Why?
Alleles
1
2021
879
0.140
Why?
Aptamers, Nucleotide
1
2019
85
0.130
Why?
Immunoglobulin A
1
2019
214
0.130
Why?
Delphi Technique
1
2019
329
0.130
Why?
Gas Chromatography-Mass Spectrometry
1
2018
131
0.130
Why?
Nontuberculous Mycobacteria
1
2019
208
0.130
Why?
Infant, Newborn
4
2024
6429
0.130
Why?
Safety
1
2019
356
0.130
Why?
Consensus
1
2019
488
0.130
Why?
Blood Proteins
1
2019
249
0.130
Why?
Volatile Organic Compounds
1
2018
60
0.130
Why?
Membrane Transport Modulators
1
2017
7
0.130
Why?
Aldehyde Oxidoreductases
1
2017
29
0.130
Why?
Trimethoprim, Sulfamethoxazole Drug Combination
1
2016
42
0.120
Why?
Rifampin
1
2017
82
0.120
Why?
Azithromycin
2
2023
104
0.120
Why?
Respiratory Mucosa
1
2019
322
0.120
Why?
Pilot Projects
2
2023
1886
0.120
Why?
Foundations
1
2016
27
0.120
Why?
Cohort Studies
2
2017
5960
0.110
Why?
Cholesterol Esters
1
2015
7
0.110
Why?
Patient Selection
1
2019
719
0.110
Why?
Pulmonary Medicine
1
2016
79
0.110
Why?
Radiography
1
2017
844
0.110
Why?
Staphylococcus aureus
2
2018
455
0.110
Why?
Longitudinal Studies
3
2021
2947
0.110
Why?
Regression Analysis
1
2017
1003
0.110
Why?
Retrospective Studies
5
2025
17066
0.110
Why?
Bronchi
1
2016
267
0.110
Why?
Immunoglobulin G
1
2019
893
0.110
Why?
Enterobacteriaceae
1
2015
43
0.110
Why?
Mycobacterium Infections, Nontuberculous
1
2019
366
0.110
Why?
Staphylococcus
1
2015
74
0.110
Why?
Double-Blind Method
1
2019
2029
0.110
Why?
Enterobacteriaceae Infections
1
2015
41
0.110
Why?
Stenotrophomonas maltophilia
1
2014
1
0.110
Why?
Achromobacter denitrificans
1
2014
1
0.110
Why?
Administration, Oral
3
2023
847
0.100
Why?
Forced Expiratory Volume
3
2020
449
0.100
Why?
Spirometry
1
2015
231
0.100
Why?
Genotyping Techniques
1
2014
69
0.100
Why?
Multivariate Analysis
1
2017
1539
0.100
Why?
Chronic Disease
1
2019
1813
0.100
Why?
Genetic Markers
1
2014
331
0.100
Why?
Biomarkers
5
2020
4271
0.100
Why?
DNA Mutational Analysis
1
2014
406
0.100
Why?
Blood Glucose
2
2025
2327
0.090
Why?
Middle Aged
5
2025
35875
0.090
Why?
Leukocyte Elastase
1
2012
75
0.090
Why?
Asthma
1
2024
1767
0.090
Why?
Administration, Inhalation
2
2023
574
0.090
Why?
Proteomics
1
2019
1195
0.090
Why?
Sequence Analysis, DNA
1
2015
824
0.090
Why?
Proteolysis
1
2012
173
0.090
Why?
Feces
1
2015
513
0.090
Why?
Animals
4
2019
38058
0.090
Why?
DNA Barcoding, Taxonomic
1
2011
27
0.090
Why?
Biota
1
2011
35
0.080
Why?
Phenotype
1
2019
3162
0.080
Why?
Neonatal Screening
1
2012
178
0.080
Why?
Risk Assessment
1
2019
3671
0.070
Why?
Intestinal Mucosa
1
2015
676
0.070
Why?
Morbidity
1
2009
323
0.070
Why?
Practice Guidelines as Topic
1
2016
1560
0.070
Why?
Pediatrics
1
2016
1114
0.070
Why?
Gastrointestinal Microbiome
1
2015
771
0.060
Why?
Cross-Sectional Studies
2
2021
5868
0.060
Why?
Cytochrome P-450 CYP3A
1
2026
93
0.060
Why?
Follow-Up Studies
1
2014
5408
0.050
Why?
Dose-Response Relationship, Drug
2
2020
2027
0.050
Why?
Catheters, Indwelling
1
2023
96
0.050
Why?
Reproducibility of Results
1
2010
3409
0.050
Why?
Pregnancy
2
2026
7190
0.050
Why?
Anaerobiosis
1
2021
64
0.040
Why?
Aged
1
2021
25913
0.040
Why?
Styrenes
1
2020
4
0.040
Why?
Porphyrins
1
2020
16
0.040
Why?
Colistin
1
2020
10
0.040
Why?
Fluorobenzenes
1
2020
17
0.040
Why?
Pyridinium Compounds
1
2020
31
0.040
Why?
Serologic Tests
1
2019
53
0.040
Why?
Dysbiosis
1
2021
187
0.040
Why?
Diagnostic Tests, Routine
1
2019
108
0.040
Why?
Medical History Taking
1
2019
117
0.040
Why?
Immunity, Humoral
1
2019
120
0.030
Why?
Incidence
1
2025
2879
0.030
Why?
Prevalence
1
2025
2834
0.030
Why?
Fluorocarbons
1
2020
143
0.030
Why?
Homozygote
1
2018
199
0.030
Why?
Symptom Assessment
1
2019
137
0.030
Why?
Cytochrome P-450 CYP3A Inducers
1
2017
5
0.030
Why?
Glucose Tolerance Test
1
2018
361
0.030
Why?
Area Under Curve
1
2018
330
0.030
Why?
Chlorhexidine
1
2016
23
0.030
Why?
Minocycline
1
2016
22
0.030
Why?
Biological Availability
1
2017
142
0.030
Why?
Biphenyl Compounds
1
2017
68
0.030
Why?
Severity of Illness Index
1
2025
2925
0.030
Why?
Anti-Infective Agents, Local
1
2016
40
0.030
Why?
Registries
1
2025
2385
0.030
Why?
ROC Curve
1
2018
614
0.030
Why?
Drug Interactions
1
2017
398
0.030
Why?
Pharmacogenetics
1
2017
172
0.030
Why?
Capsule Endoscopes
1
2015
7
0.030
Why?
Hypoglycemic Agents
1
2025
1387
0.030
Why?
Leukocyte L1 Antigen Complex
1
2015
40
0.030
Why?
Permeability
1
2015
168
0.030
Why?
Telemedicine
1
2024
945
0.030
Why?
Nanoparticles
1
2020
519
0.030
Why?
Drug Monitoring
1
2017
395
0.020
Why?
Autoimmunity
1
2019
926
0.020
Why?
Liver Cirrhosis
1
2015
288
0.020
Why?
Blotting, Western
1
2015
1187
0.020
Why?
Genetic Carrier Screening
1
2012
32
0.020
Why?
Trypsinogen
1
2012
11
0.020
Why?
Decision Making
1
2019
975
0.020
Why?
False Positive Reactions
1
2012
121
0.020
Why?
DNA
1
2018
1463
0.020
Why?
Surveys and Questionnaires
1
2023
6048
0.020
Why?
Prognosis
1
2018
4282
0.020
Why?
Bacterial Proteins
1
2016
955
0.020
Why?
Proteins
1
2015
1021
0.020
Why?
Genes, rRNA
1
2007
42
0.020
Why?
Genes, Bacterial
1
2007
166
0.020
Why?
Risk Factors
1
2019
10779
0.010
Why?
Molecular Sequence Data
1
2007
2930
0.010
Why?
Zemanick's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)